Accelerate Diagnostics, Inc. (0H8E.L)
USD 0.57
(-14.24%)
USD 0.57
(-14.24%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 56.57 Million USD | -14.42% |
| 2022 | 66.1 Million USD | -7.12% |
| 2021 | 71.17 Million USD | 4.43% |
| 2020 | 68.15 Million USD | -11.75% |
| 2019 | 77.23 Million USD | -4.48% |
| 2018 | 80.85 Million USD | 22.58% |
| 2017 | 65.95 Million USD | 0.55% |
| 2016 | 65.59 Million USD | 49.41% |
| 2015 | 43.9 Million USD | 41.12% |
| 2014 | 31.11 Million USD | 102.57% |
| 2013 | 15.35 Million USD | 87.12% |
| 2012 | 8.2 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 9.28 Million USD | -14.68% |
| 2024 Q1 | 10.87 Million USD | -4.26% |
| 2023 Q3 | 15.94 Million USD | 19.1% |
| 2023 Q1 | 17.07 Million USD | 15.35% |
| 2023 Q2 | 13.38 Million USD | -21.61% |
| 2023 Q4 | 11.36 Million USD | -28.72% |
| 2023 FY | 56.57 Million USD | -14.42% |
| 2022 Q4 | 14.8 Million USD | -4.76% |
| 2022 Q3 | 15.54 Million USD | -18.51% |
| 2022 Q1 | 16.69 Million USD | 3.75% |
| 2022 FY | 66.1 Million USD | -7.12% |
| 2022 Q2 | 19.06 Million USD | 14.21% |
| 2021 Q3 | 15.51 Million USD | -16.76% |
| 2021 FY | 71.17 Million USD | 4.43% |
| 2021 Q1 | 20.92 Million USD | 29.58% |
| 2021 Q4 | 16.09 Million USD | 3.71% |
| 2021 Q2 | 18.64 Million USD | -10.9% |
| 2020 FY | 68.15 Million USD | -11.75% |
| 2020 Q1 | 18.99 Million USD | -3.91% |
| 2020 Q4 | 16.14 Million USD | -0.65% |
| 2020 Q3 | 16.25 Million USD | -1.94% |
| 2020 Q2 | 16.57 Million USD | -12.75% |
| 2019 Q2 | 18.98 Million USD | -3.73% |
| 2019 FY | 77.23 Million USD | -4.48% |
| 2019 Q4 | 19.76 Million USD | 4.56% |
| 2019 Q3 | 18.9 Million USD | -0.4% |
| 2019 Q1 | 19.71 Million USD | -3.37% |
| 2018 Q2 | 21.66 Million USD | 2.79% |
| 2018 Q1 | 21.08 Million USD | 18.51% |
| 2018 FY | 80.85 Million USD | 22.58% |
| 2018 Q4 | 20.4 Million USD | 1.13% |
| 2018 Q3 | 20.17 Million USD | -6.88% |
| 2017 Q1 | 14.83 Million USD | -7.53% |
| 2017 FY | 65.95 Million USD | 0.55% |
| 2017 Q4 | 17.78 Million USD | -1.13% |
| 2017 Q3 | 17.99 Million USD | 5.83% |
| 2017 Q2 | 16.99 Million USD | 14.55% |
| 2016 Q2 | 18.02 Million USD | 17.89% |
| 2016 Q3 | 17.48 Million USD | -3.02% |
| 2016 FY | 65.59 Million USD | 49.41% |
| 2016 Q4 | 16.04 Million USD | -8.2% |
| 2016 Q1 | 15.29 Million USD | 15.8% |
| 2015 Q2 | 12.28 Million USD | 37.67% |
| 2015 Q3 | 11.29 Million USD | -8.05% |
| 2015 FY | 43.9 Million USD | 41.12% |
| 2015 Q1 | 8.92 Million USD | 7.14% |
| 2015 Q4 | 13.2 Million USD | 16.88% |
| 2014 Q4 | 8.33 Million USD | -5.8% |
| 2014 Q3 | 8.84 Million USD | 8.13% |
| 2014 Q2 | 8.17 Million USD | 41.95% |
| 2014 Q1 | 5.76 Million USD | 11.04% |
| 2014 FY | 31.11 Million USD | 102.57% |
| 2013 Q4 | 5.18 Million USD | 35.85% |
| 2013 FY | 15.35 Million USD | 87.12% |
| 2013 Q2 | 3.78 Million USD | 47.54% |
| 2013 Q1 | 2.56 Million USD | -11.53% |
| 2013 Q3 | 3.81 Million USD | 0.87% |
| 2012 Q4 | 2.9 Million USD | 0.0% |
| 2012 FY | 8.2 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| QuidelOrtho Corporation | 1.35 Billion USD | 95.825% |